Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (142)	10/21/1998 8:37:00 PM
From: scaram(o)uche	Read Replies (4) \| Respond to of 1073

Richard: Thanks! I think that our resident and most vociferous "doubter" is Miljenko. Has Blitzer pointed anyone to preclinical toxicology data? I'm still interested. As you know, however, I don't buy Blitzer's Europe versus U.S. argument. There are ways to structure worldwide agreements to achieve the same end. The thought was floated (not by you) in the MOGN thread that the Europe deal would be sealed by the time phase II trials were initiated. Didn't happen. Blitzer will either be very successful or look sillier than the average bear. MOGN's the star of the portfolio. We'll keep it. Cheers! Rick